by GlobeNewsWire | Sep 1, 2016 | Globe Newswire
BERKELEY HEIGHTS, N.J., Sept. 01, 2016 (GLOBE NEWSWIRE) — Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions, today announced that...
by GlobeNewsWire | Sep 1, 2016 | Globe Newswire
ATLANTA, Sept. 01, 2016 (GLOBE NEWSWIRE) — Aviragen Therapeutics, Inc. (NASDAQ:AVIR) (formerly Biota Pharmaceuticals, Inc.), a pharmaceutical company that is developing the next generation of antivirals, today announced that management will host a conference...
by GlobeNewsWire | Aug 19, 2016 | Globe Newswire
Kim Dorney to give opening keynote to cervical cancer survivors PRINCETON, N.J., Aug. 19, 2016 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS) a clinical-stage biotechnology company developing cancer immunotherapies, is pleased to participate in Cervivor School...
by GlobeNewsWire | Aug 16, 2016 | Globe Newswire
PRINCETON, N.J., Aug. 16, 2016 (GLOBE NEWSWIRE) — Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that it has entered into a definitive securities purchase agreement with healthcare...
by GlobeNewsWire | Aug 9, 2016 | Globe Newswire
NEW YORK, Aug. 09, 2016 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported financial results for the...